Literature DB >> 26010517

Intermittent cardiac overload results in adaptive hypertrophy and provides protection against left ventricular acute pressure overload insult.

Daniel Moreira-Gonçalves1,2, Tiago Henriques-Coelho2, Hélder Fonseca1, Rita Ferreira3, Ana Isabel Padrão3, Cátia Santa3, Sara Vieira1, Ana Filipa Silva2, Francisco Amado3, Adelino Leite-Moreira2,4, José Alberto Duarte1.   

Abstract

The present study aimed to test whether a chronic intermittent workload could induce an adaptive cardiac phenotype Chronic intermittent workload induced features of adaptive hypertrophy This was paralleled by protection against acute pressure overload insult The heart may adapt favourably to balanced demands, regardless of the nature of the stimuli. The present study aimed to test whether submitting the healthy heart to intermittent and tolerable amounts of workload, independently of its nature, could result in an adaptive cardiac phenotype. Male Wistar rats were subjected to treadmill running (Ex) (n = 20), intermittent cardiac overload with dobutamine (ITO) (2 mg kg(-1) , s.c.; n = 20) or placebo administration (Cont) (n = 20) for 5 days week(-1) for 8 weeks. Animals were then killed for histological and biochemical analysis or subjected to left ventricular haemodynamic evaluation under baseline conditions, in response to isovolumetric contractions and to sustained LV acute pressure overload (35% increase in peak systolic pressure maintained for 2 h). Baseline cardiac function was enhanced only in Ex, whereas the response to isovolumetric heartbeats was improved in both ITO and Ex. By contrast to the Cont group, in which rats developed diastolic dysfunction with sustained acute pressure overload, ITO and Ex showed increased tolerance to this stress test. Both ITO and Ex developed cardiomyocyte hypertrophy without fibrosis, no overexpression of osteopontin-1 or β-myosin heavy chain, and increased expression of sarcoplasmic reticulum Ca(2+) protein. Regarding hypertrophic pathways, ITO and Ex showed activation of the protein kinase B/mammalian target of rapamycin pathway but not calcineurin. Mitochondrial complex IV and V activities were also increased in ITO and Ex. Chronic submission to controlled intermittent cardiac overload, independently of its nature, results in an adaptive cardiac phenotype. Features of the cardiac overload, such as the duration and magnitude of the stimuli, may play a role in the development of an adaptive or maladaptive phenotype.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26010517      PMCID: PMC4575575          DOI: 10.1113/JP270685

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  40 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis.

Authors:  António Ascensão; José Magalhães; José M C Soares; Rita Ferreira; Maria J Neuparth; Franklim Marques; Paulo J Oliveira; José A Duarte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-03-25       Impact factor: 4.733

3.  A prediction model for left ventricular mass in patients at high cardiovascular risk.

Authors:  Matthijs F L Meijs; Yvonne Vergouwe; Maarten J M Cramer; Evert-Jan A Vonken; Birgitta K Velthuis; David J Verton; Yolanda van der Graaf; Frank L Visseren; Willem P Mali; Pieter A Doevendans; Michiel L Bots
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-12

4.  Dobutamine-induced cardiac adaptations: comparison with exercise-trained and sedentary rats.

Authors:  W R Davidson; S P Banerjee; C S Liang
Journal:  Am J Physiol       Date:  1986-05

5.  Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.

Authors:  Ron Rice; Pia Guinto; Candice Dowell-Martino; Huamei He; Kirsten Hoyer; Maike Krenz; Jeffrey Robbins; Joanne S Ingwall; Jil C Tardiff
Journal:  J Mol Cell Cardiol       Date:  2009-12-31       Impact factor: 5.000

Review 6.  The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy.

Authors:  Jenny Y Y Ooi; Bianca C Bernardo; Julie R McMullen
Journal:  Future Med Chem       Date:  2014-02       Impact factor: 3.808

7.  The effect of dobutamine on myocardial performance and high-energy phosphate metabolism at different stages of heart failure in cardiomyopathic hamsters: a 31P MRS study.

Authors:  P T Buser; S A Camacho; S T Wu; C B Higgins; G Jasmin; W W Parmley; J Wikman-Coffelt
Journal:  Am Heart J       Date:  1989-07       Impact factor: 4.749

8.  Effects of myosin heavy chain manipulation in experimental heart failure.

Authors:  Jeanne James; Kan Hor; Michael-Alice Moga; Lisa Ann Martin; Jeffrey Robbins
Journal:  J Mol Cell Cardiol       Date:  2009-10-22       Impact factor: 5.000

9.  Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.

Authors:  Ole Johan Kemi; Marcello Ceci; Ulrik Wisloff; Serena Grimaldi; Paolo Gallo; Godfrey L Smith; Gianluigi Condorelli; Oyvind Ellingsen
Journal:  J Cell Physiol       Date:  2008-02       Impact factor: 6.384

10.  Oxygen cost of treadmill running in 24-month-old Fischer-344 rats.

Authors:  J M Lawler; S K Powers; J Hammeren; A D Martin
Journal:  Med Sci Sports Exerc       Date:  1993-11       Impact factor: 5.411

View more
  11 in total

1.  Pathological vs. physiological cardiac hypertrophy.

Authors:  Andreas N Kavazis
Journal:  J Physiol       Date:  2015-09-01       Impact factor: 5.182

2.  Nature versus exposure: matched exposure to circulatory stressors of different natures elicits adaptive remodelling.

Authors:  S Wright; R Lakin
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

3.  One year of exercise training promotes distinct adaptations in right and left ventricle of female Sprague-Dawley rats.

Authors:  Rita Nogueira-Ferreira; Rita Ferreira; Ana Isabel Padrão; Paula Oliveira; Manuel Santos; Andreas N Kavazis; Rui Vitorino; Daniel Moreira-Gonçalves
Journal:  J Physiol Biochem       Date:  2019-10-16       Impact factor: 4.158

Review 4.  Darwinian evolution and cardiovascular remodeling.

Authors:  Bernard Swynghedauw
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

5.  Speckle Tracking Based Strain Analysis Is Sensitive for Early Detection of Pathological Cardiac Hypertrophy.

Authors:  Xiangbo An; Jingjing Wang; Hao Li; Zhizhen Lu; Yan Bai; Han Xiao; Youyi Zhang; Yao Song
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

6.  Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors.

Authors:  Caroline R Archer; Emma L Robinson; Faye M Drawnel; H Llewelyn Roderick
Journal:  Cell Signal       Date:  2017-04-13       Impact factor: 4.315

Review 7.  Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease.

Authors:  Ahmed S Bayoumi; Amer Sayed; Zuzana Broskova; Jian-Peng Teoh; James Wilson; Huabo Su; Yao-Liang Tang; Il-Man Kim
Journal:  Int J Mol Sci       Date:  2016-03-11       Impact factor: 5.923

8.  Comorbid CAD and ventricular hypertrophy compromise the perfusion of myocardial tissue at subcritical stenosis of epicardial coronaries.

Authors:  Eslam Abbas
Journal:  Egypt Heart J       Date:  2019-08-05

9.  Exercise preconditioning prevents left ventricular dysfunction and remodeling in monocrotaline-induced pulmonary hypertension.

Authors:  Cristine Schmidt; José A Bovolini; Nádia Gonçalves; Francisco Vasques-Nóvoa; Maria do Amparo Andrade; Mário Santos; Adelino Leite-Moreira; Tiago Henriques-Coelho; José Alberto Duarte; Daniel Moreira-Gonçalves
Journal:  Porto Biomed J       Date:  2020-09-16

Review 10.  Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease.

Authors:  Kevin M Casin; John W Calvert
Journal:  Antioxidants (Basel)       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.